126 related articles for article (PubMed ID: 2499113)
1. Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens.
Ikuta K; Morita C; Miyake S; Ito T; Okabayashi M; Sano K; Nakai M; Hirai K; Kato S
Virology; 1989 Jun; 170(2):408-17. PubMed ID: 2499113
[TBL] [Abstract][Full Text] [Related]
2. Application of scanning electron microscopy (SEM) and microbead techniques to study the localization of p24 and p18 antigens of HIV-1 on the surface of HIV-1-infected H9-lymphocytes.
Dennin RH; Beyer A
J Microsc; 1991 Oct; 164(Pt 1):53-60. PubMed ID: 1757990
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
4. Epitope location of 13 anti-gag HIV-1 monoclonal antibodies using oligopeptides and their cross reactivity with HIV-2.
Ferns RB; Partridge JC; Spence RP; Hunt N; Tedder RS
AIDS; 1989 Dec; 3(12):829-34. PubMed ID: 2483619
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of infected cell appearance as a determinant of number of human immunodeficiency virus-1 infectious units.
Cory JM; Ohlsson-Wilhelm BM; Steck ME; Smithgall MD; Rozday V; Eyster ME; Rapp F
AIDS Res Hum Retroviruses; 1989 Feb; 5(1):97-106. PubMed ID: 2497763
[TBL] [Abstract][Full Text] [Related]
6. [The properties of monoclonal antibodies to HIV gag gene proteins].
Kushch AA; Tugizov ShM; Simonov VI; Timofeev IV; Perminova NP; Shumaĭ EP
Vopr Virusol; 1991; 36(4):275-7. PubMed ID: 1796579
[TBL] [Abstract][Full Text] [Related]
7. Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation.
Ferns RB; Tedder RS; Weiss RA
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1543-51. PubMed ID: 2438375
[TBL] [Abstract][Full Text] [Related]
8. Major core proteins, p24s, of human, simian, and feline immunodeficiency viruses are partly expressed on the surface of the virus-infected cells.
Nishino Y; Ohki K; Kimura T; Morikawa S; Mikami T; Ikuta K
Vaccine; 1992; 10(10):677-83. PubMed ID: 1326145
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells.
Ota A; Ueda S
Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237
[TBL] [Abstract][Full Text] [Related]
10. Cell surface expression of several species of human immunodeficiency virus type 1 major core protein.
Laurent AG; Krust B; Rey MA; Montagnier L; Hovanessian AG
J Virol; 1989 Sep; 63(9):4074-8. PubMed ID: 2503623
[TBL] [Abstract][Full Text] [Related]
11. The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.
Goto T; Ikuta K; Zhang JJ; Morita C; Sano K; Komatsu M; Fujita H; Kato S; Nakai M
Arch Virol; 1990; 111(1-2):87-101. PubMed ID: 1691624
[TBL] [Abstract][Full Text] [Related]
12. Comparison of core antigen (p24) assay and reverse transcriptase activity for detection of human immunodeficiency virus type 1 replication.
Land S; Beaton F; McPhee DA; Gust ID
J Clin Microbiol; 1989 Mar; 27(3):486-9. PubMed ID: 2469698
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a flow cytometric model for monitoring HIV antigen expression in vitro.
Heynen CA; Holzer TJ
J Immunol Methods; 1992 Jul; 152(1):25-33. PubMed ID: 1640108
[TBL] [Abstract][Full Text] [Related]
14. [Expression and characterization of HIV-1 Gag p17-p24 protein].
Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
[TBL] [Abstract][Full Text] [Related]
15. Replication of human immunodeficiency virus in two T-cell lines and their application as antigens for immunofluorescence.
Kawatani T; Hattori N; Kurimura T
Microbiol Immunol; 1988; 32(5):491-8. PubMed ID: 3050377
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.
Flexner C; Broyles SS; Earl P; Chakrabarti S; Moss B
Virology; 1988 Oct; 166(2):339-49. PubMed ID: 2459842
[TBL] [Abstract][Full Text] [Related]
17. Characterization of three monoclonal antibodies (VAK3-5) that identify p24, core protein of human immunodeficiency virus, and its precursors.
Hattori T; Sagawa K; Matsushita S; Koito A; Suto H; Matsuoka M; Yokoyama M; Takatsuki K
Jpn J Cancer Res; 1987 Mar; 78(3):235-41. PubMed ID: 3106279
[TBL] [Abstract][Full Text] [Related]
18. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome.
Shattles WG; Brookes SM; Venables PJ; Clark DA; Maini RN
Clin Exp Immunol; 1992 Jul; 89(1):46-51. PubMed ID: 1628425
[TBL] [Abstract][Full Text] [Related]
19. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
[TBL] [Abstract][Full Text] [Related]
20. Persistently human immunodeficiency virus type 1-infected T cell clone expressing only doubly spliced mRNA exhibits reduced cell surface CD4 expression.
Kishi M; Nishino Y; Ohki K; Kimura T; Ikuta K
Jpn J Cancer Res; 1993 Feb; 84(2):153-62. PubMed ID: 8463132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
